$ELDN
Eledon Pharmaceuticals, Inc.

2020 Q1 Form 10-K Financial Statement

#000156459020011260 Filed on March 17, 2020

View on sec.gov

Income Statement

Concept 2020 Q1 2019 2018 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.730M $6.060M $1.840M
YoY Change -8.47% -16.3% 14.29%
% of Gross Profit
Research & Development $1.648M $8.128M $2.740M
YoY Change -44.88% 19.23% 459.18%
% of Gross Profit
Depreciation & Amortization $0.00 $10.00K $0.00
YoY Change 0.0%
% of Gross Profit
Operating Expenses $3.378M $16.05M $4.580M
YoY Change -30.78% 135.46% 117.06%
Operating Profit -$3.378M
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $30.00K $40.00K $0.00
YoY Change -600.0% -500.0% -100.0%
Pretax Income -$8.177M -$16.01M -$4.570M
YoY Change 67.56% 12.94% 116.59%
Income Tax
% Of Pretax Income
Net Earnings -$8.177M -$16.01M -$4.570M
YoY Change 67.53% 13.83% 116.59%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$8.521M -$24.26M -$8.788M
COMMON SHARES
Basic Shares Outstanding 16.07M 9.422M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q1 2019 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.80M $8.800M $13.00M
YoY Change 29.67% -32.31% -24.42%
Cash & Equivalents $11.79M $8.800M $12.97M
Short-Term Investments
Other Short-Term Assets $64.00K $1.000M $36.00K
YoY Change 137.04% -23.08% 100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.90M $10.00M $14.28M
YoY Change 24.99% -30.07% -24.86%
LONG-TERM ASSETS
Property, Plant & Equipment $300.0K $300.0K $14.00K
YoY Change 2400.0% -44.0%
Goodwill $1.867M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $572.0K $600.0K $869.0K
YoY Change -28.5% -33.33%
Total Long-Term Assets $820.0K $900.0K $2.750M
YoY Change -74.21% -66.67% 45.35%
TOTAL ASSETS
Total Short-Term Assets $12.90M $10.00M $14.28M
Total Long-Term Assets $820.0K $900.0K $2.750M
Total Assets $13.72M $10.90M $17.03M
YoY Change 1.63% -35.88% -18.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $741.0K $300.0K $689.0K
YoY Change 48.2% -57.14% 64.83%
Accrued Expenses $1.100M $1.000M $1.800M
YoY Change -60.71% -44.44% 80.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.878M $1.300M $2.534M
YoY Change -42.05% -48.0% 81.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $100.0K
YoY Change -66.67%
Total Long-Term Liabilities $100.0K $100.0K $0.00
YoY Change -66.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.878M $1.300M $2.534M
Total Long-Term Liabilities $100.0K $100.0K $0.00
Total Liabilities $2.000M $1.500M $2.534M
YoY Change -43.21% -40.0% 75.97%
SHAREHOLDERS EQUITY
Retained Earnings -$41.57M
YoY Change 51.13%
Common Stock $56.06M
YoY Change 19.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $11.75M $9.500M $14.49M
YoY Change
Total Liabilities & Shareholders Equity $13.70M $10.90M $17.03M
YoY Change 1.85% -35.88% -18.5%

Cashflow Statement

Concept 2020 Q1 2019 2018 Q4
OPERATING ACTIVITIES
Net Income -$8.177M -$16.01M -$4.570M
YoY Change 67.53% 13.83% 116.59%
Depreciation, Depletion And Amortization $0.00 $10.00K $0.00
YoY Change 0.0%
Cash From Operating Activities -$2.197M -$13.86M -$3.350M
YoY Change -45.39% 16.51% 28.35%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.676M
YoY Change 29.17%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 5.191M 9.676M 0.000
YoY Change 4751.4% 27.96% -100.0%
NET CHANGE
Cash From Operating Activities -2.197M -13.86M -3.350M
Cash From Investing Activities 0.000
Cash From Financing Activities 5.191M 9.676M 0.000
Net Change In Cash 2.994M -4.181M -3.350M
YoY Change -176.46% -3.46% 80.11%
FREE CASH FLOW
Cash From Operating Activities -$2.197M -$13.86M -$3.350M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16069562
CY2019Q2 dei Entity Public Float
EntityPublicFloat
9638037
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8791000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1180000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
9971000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5000
CY2019 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2018Q4 us-gaap Goodwill
Goodwill
1867000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
869000
CY2018Q4 us-gaap Assets
Assets
17026000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
689000
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
1867000
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Operating Expenses
OperatingExpenses
16051000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-14060000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.36
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.56
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
11799468
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9005352
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
19452000
CY2018 nvus Share Issuance At Market Value
ShareIssuanceAtMarketValue
7491000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
71000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1543000
CY2019 nvus Share Issuance At Market Value
ShareIssuanceAtMarketValue
107000
CY2019 nvus Stock Issued During Period Value Common Stock And Warrants
StockIssuedDuringPeriodValueCommonStockAndWarrants
9569000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11000
CY2019 nvus Amortization Of Operating Lease Asset
AmortizationOfOperatingLeaseAsset
173000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1308000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-354000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
476000
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity File Number
EntityFileNumber
001-36620
CY2019 dei Entity Address Address Line1
EntityAddressAddressLine1
19900 MacArthur Boulevard
CY2019 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 550
CY2019 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2019 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2019 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92612
CY2019 dei City Area Code
CityAreaCode
(949)
CY2019 dei Local Phone Number
LocalPhoneNumber
238-8090
CY2019 dei Document Annual Report
DocumentAnnualReport
true
CY2019 dei Document Transition Report
DocumentTransitionReport
false
CY2019 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12972000
CY2019 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-1000967
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1304000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
14276000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
316000
CY2019 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6056000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9422143
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9422143
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1308000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1392000
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1094000
CY2019 nvus Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-165000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13857000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
9676000
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7491000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
71000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9676000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7562000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4181000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4331000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12972000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17303000
CY2019Q4 nvus Income Tax Examination Likelihood Of Favorable Settlement
IncomeTaxExaminationLikelihoodOfFavorableSettlement
0.50
CY2019 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.86%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the reported amounts of assets, liabilities and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s financial statements relate to stock-based compensation, accruals for liabilities, operating lease liability, carrying value of goodwill, and other matters that affect the consolidated financial statements and related disclosures. Actual results could differ materially from those estimates under different assumptions or conditions and the differences may be material to the consolidated financial statements. </p>
CY2019 us-gaap Lease Practical Expedient Use Of Hindsight
LeasePracticalExpedientUseOfHindsight
false
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
734000
CY2019Q4 nvus Working Capital
WorkingCapital
8600000
CY2019Q3 nvus Closing Bid Price Per Nasdaq Listing Notification Letter
ClosingBidPricePerNASDAQListingNotificationLetter
1.00
CY2019Q3 nvus Consecutive Business Days For Closing Bid Price Of Common Stock
ConsecutiveBusinessDaysForClosingBidPriceOfCommonStock
P30D
CY2019 nvus Cash Cash Equivalents And Restricted Cash Maturity Period
CashCashEquivalentsAndRestrictedCashMaturityPeriod
three months or less
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2018Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2018Q4 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2018Q4 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
245000
CY2019 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1
CY2019 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8770947
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
974817
CY2019 us-gaap Tax Cuts And Jobs Act Of2017 Change In Tax Rate Income Tax Expense Benefit
TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit
0
CY2018Q4 us-gaap Prepaid Insurance
PrepaidInsurance
413000
CY2019 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.
CY2019 nvus Number Of Milestones Achieved
NumberOfMilestonesAchieved
0
CY2018 nvus Number Of Milestones Achieved
NumberOfMilestonesAchieved
0
CY2019Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2019Q4 nvus Contingent Liability
ContingentLiability
0
CY2019Q4 nvus Prepaid Clinical Expense
PrepaidClinicalExpense
102000
CY2018Q4 nvus Prepaid Clinical Expense
PrepaidClinicalExpense
208000
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
45000
CY2018Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
53000
CY2018Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
594000
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
170000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
54000
CY2018Q4 us-gaap Other Assets Current
OtherAssetsCurrent
36000
CY2019Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
40000
CY2018Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
742000
CY2019Q4 nvus Accrued Clinical Current
AccruedClinicalCurrent
437000
CY2018Q4 nvus Accrued Clinical Current
AccruedClinicalCurrent
735000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
130000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
194000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
199000
CY2018Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
160000
CY2019Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
7000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
14000
CY2017Q4 us-gaap Goodwill Gross
GoodwillGross
1867000
CY2018Q4 us-gaap Goodwill Gross
GoodwillGross
1867000
CY2019Q4 us-gaap Goodwill Gross
GoodwillGross
1867000
CY2019Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
1867000
CY2017Q4 us-gaap Goodwill
Goodwill
1867000
CY2019 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
188000
CY2019 nvus Lessee Operating Lease Remaining Term Of Contract
LesseeOperatingLeaseRemainingTermOfContract
P1Y9M
CY2019Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
0
CY2019 us-gaap Operating Lease Cost
OperatingLeaseCost
196000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
180000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
489000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0325
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
188000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
146000
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
334000
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
10000
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
324000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
180000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
188000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
146000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
514000
CY2018Q4 nvus Contingent Liability
ContingentLiability
0
CY2019 nvus Number Of Stock Compensation Plans
NumberOfStockCompensationPlans
2
CY2019 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.111111111
CY2019 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one for nine
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2019Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1300000
CY2019 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y2M12D
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.74
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.63
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.77
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.86
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.01
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.02
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.03
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.03
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16174000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-14177000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
163000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
112000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-16011000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14065000
CY2018 nvus Effective Federal And State Income Tax Rate
EffectiveFederalAndStateIncomeTaxRate
0.21
CY2019 nvus Effective Federal And State Income Tax Rate
EffectiveFederalAndStateIncomeTaxRate
0.21
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-3362000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2953000
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
207000
CY2018 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
204000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
141000
CY2018 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
72000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Impairment Losses
IncomeTaxReconciliationNondeductibleExpenseImpairmentLosses
392000
CY2019 nvus Income Tax Reconciliation Permanent Items
IncomeTaxReconciliationPermanentItems
4000
CY2018 nvus Income Tax Reconciliation Permanent Items
IncomeTaxReconciliationPermanentItems
3000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
38000
CY2018 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
90000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2994000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
2992000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
9947000
CY2018Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7126000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
506000
CY2018Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
299000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
43000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
159000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
391000
CY2018Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
301000
CY2019Q4 nvus Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
116000
CY2018Q4 nvus Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
126000
CY2019Q4 nvus Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
68000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
11071000
CY2018Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
8011000
CY2019Q4 nvus Deferred Tax Assets Right Of Use Asset
DeferredTaxAssetsRightOfUseAsset
66000
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
66000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11005000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
8011000
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
328000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
181000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
214000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
158000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
6000
CY2018 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
11000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
548000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
3000000
CY2019 nvus Period For Which Cumulative Change In Ownership Annual Use Net Operating Loss And Research And Development Credit Carryforwards
PeriodForWhichCumulativeChangeInOwnershipAnnualUseNetOperatingLossAndResearchAndDevelopmentCreditCarryforwards
P3Y
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7070680
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2019 nvus Class Of Warrant Or Right Number Of Warrants Or Rights Issued
ClassOfWarrantOrRightNumberOfWarrantsOrRightsIssued
7070680
CY2019 nvus Class Of Warrant Or Right Number Of Warrants Or Rights Exercised
ClassOfWarrantOrRightNumberOfWarrantsOrRightsExercised
0
CY2019 nvus Class Of Warrant Or Right Number Of Warrants Or Rights Expired
ClassOfWarrantOrRightNumberOfWarrantsOrRightsExpired
0

Files In Submission

Name View Source Status
0001564590-20-011260-index-headers.html Edgar Link pending
0001564590-20-011260-index.html Edgar Link pending
0001564590-20-011260.txt Edgar Link pending
0001564590-20-011260-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gdnwj3iwx32g000001.jpg Edgar Link pending
gdnwj3iwx32g000002.jpg Edgar Link pending
gmsxlai2fp3t000001.jpg Edgar Link pending
nvus-10k_20191231.htm Edgar Link pending
nvus-20191231.xml Edgar Link completed
nvus-20191231.xsd Edgar Link pending
nvus-20191231_cal.xml Edgar Link unprocessable
nvus-20191231_def.xml Edgar Link unprocessable
nvus-20191231_lab.xml Edgar Link unprocessable
nvus-20191231_pre.xml Edgar Link unprocessable
nvus-ex211_11.htm Edgar Link pending
nvus-ex231_451.htm Edgar Link pending
nvus-ex232_452.htm Edgar Link pending
nvus-ex311_9.htm Edgar Link pending
nvus-ex312_6.htm Edgar Link pending
nvus-ex321_12.htm Edgar Link pending
nvus-ex322_10.htm Edgar Link pending
nvus-ex44_576.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending